Status:

ACTIVE_NOT_RECRUITING

Wearable Epileptic Seizure Prediction and Alert Glasses Based on Neuromorphic Computing

Lead Sponsor:

Oman Ministry of Health

Conditions:

Epilepsy

Epileptic Seizures

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The NEXA study aims to evaluate a new wearable EEG device designed as smart glasses with dry electrodes positioned according to the 10-20 system. The device captures real-time brain signals to detect ...

Detailed Description

The NEXA Study is a prospective observational clinical trial designed to evaluate the safety, comfort, and performance of the NEXA wearable EEG device in patients with epilepsy. NEXA uses an innovativ...

Eligibility Criteria

Inclusion

  • Adults (≥18 years) with a confirmed epilepsy diagnosis by a neurologist or epilepsy specialist.
  • History of active seizures within the last year, under stable treatment (medications, VNS, diet, or surgery) for at least 3 months.
  • Capacity to provide informed consent (or via legal representative if cognitively impaired).
  • Willingness to participate and sign consent.
  • Residents of Oman attending Khoula Hospital or affiliated clinics.
  • Stable general health without acute or severe comorbidities.
  • Ability and willingness to attend study visits and follow protocols.

Exclusion

  • Seizures from non-epileptic causes (e.g., psychogenic, metabolic, tumors).
  • Under 18 years of age.
  • Severe cognitive impairment preventing consent or protocol adherence.
  • Pregnant or planning pregnancy during the study.
  • Severe uncontrolled medical conditions (e.g., heart disease, cancer).
  • History of non-compliance with epilepsy treatment or follow-ups.
  • Severe psychiatric disorders affecting participation or safety.
  • History of substance abuse interfering with study adherence.
  • Known allergies or hypersensitivity to study medications or procedures.

Key Trial Info

Start Date :

August 10 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

47 Patients enrolled

Trial Details

Trial ID

NCT07139457

Start Date

August 10 2025

End Date

December 31 2025

Last Update

October 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Khoula Hospital

Muscat, Oman